Clinical Trial Update: Neuro RX Gamma for Amnestic Mild Cognitive Impairment (aMCI) [EARLY_Phase 1]

View source ↗

Summary

The EARLY_PHASE1 trial of Neuro RX Gamma for amnestic mild cognitive impairment has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amnestic Mild Cognitive Impairment
• Cognitive Impairment

Drugs mentioned

• Neuro RX Gamma

Snippet

Sponsor: Unity Health Toronto | Conditions: MCI, Amnestic Mild Cognitive Disorder | EARLY_Phase 1 | Status: COMPLETED